Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Dosing starts in phase I/II study of Moderna's quadrivalent seasonal flu mRNA vaccine

July 8, 2021

Atossa receives approval to open phase I/II study of AT-H201 in Australia

July 8, 2021

Centivax patents CR-3022-derived antibodies for SARS-CoV-2

July 8, 2021

Shaanxi Synthetic Pharmaceutical identifies new antibacterials

July 8, 2021

Ifenprodil will not advance into phase III trial for COVID-19

July 7, 2021

TruLarv standardized Galleria mellonella developed for screening new antimicrobials

July 7, 2021

Phase II FORCE study of avdoralimab in COVID-19 misses primary endpoints

July 6, 2021

Vaccinia virus-expressed SARS-CoV-2 spike protein promotes cellular and humoral immunity in mice

July 6, 2021

Initiation of phase II trial of Hepalatide in chronic hepatitis B

July 5, 2021

Results of phase I dose-escalation study of MVC-COV-1901 SARSCoV-2 vaccine candidate

July 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...